mva.5t4
Biologicalexperimental
Clinical trial activity
2 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2007 (NCT00521274)
Timeline
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mva 5t4
- mva.5t4
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02390063 | Phase 1 | Jun 1, 2015 | University of Oxford |
| NCT00521274 | Phase 2 | Aug 1, 2007 | Baylor University, Methodist Cancer Center, Houston, Texas, Oxford BioMedica |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Baylor University | Academic/Hospital | 1 | 0 | 1 | 2007 |
| Methodist Cancer Center, Houston, Texas | Academic/Hospital | 1 | 1 | 1 | 2007 |
| Oxford BioMedica | For profit | 1 | 0 | 1 | 2007 |
| University of Oxford | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1